1. Home
  2. PTHL vs MBOT Comparison

PTHL vs MBOT Comparison

Compare PTHL & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTHL
  • MBOT
  • Stock Information
  • Founded
  • PTHL 1998
  • MBOT 2010
  • Country
  • PTHL China
  • MBOT United States
  • Employees
  • PTHL N/A
  • MBOT N/A
  • Industry
  • PTHL
  • MBOT Medical/Dental Instruments
  • Sector
  • PTHL
  • MBOT Health Care
  • Exchange
  • PTHL Nasdaq
  • MBOT Nasdaq
  • Market Cap
  • PTHL 85.4M
  • MBOT 95.4M
  • IPO Year
  • PTHL 2024
  • MBOT N/A
  • Fundamental
  • Price
  • PTHL $1.10
  • MBOT $2.59
  • Analyst Decision
  • PTHL
  • MBOT Strong Buy
  • Analyst Count
  • PTHL 0
  • MBOT 1
  • Target Price
  • PTHL N/A
  • MBOT $9.00
  • AVG Volume (30 Days)
  • PTHL 3.2M
  • MBOT 2.0M
  • Earning Date
  • PTHL 02-11-2025
  • MBOT 08-13-2025
  • Dividend Yield
  • PTHL N/A
  • MBOT N/A
  • EPS Growth
  • PTHL N/A
  • MBOT N/A
  • EPS
  • PTHL N/A
  • MBOT N/A
  • Revenue
  • PTHL $448,196.00
  • MBOT N/A
  • Revenue This Year
  • PTHL N/A
  • MBOT N/A
  • Revenue Next Year
  • PTHL N/A
  • MBOT $400.00
  • P/E Ratio
  • PTHL N/A
  • MBOT N/A
  • Revenue Growth
  • PTHL N/A
  • MBOT N/A
  • 52 Week Low
  • PTHL $0.60
  • MBOT $0.82
  • 52 Week High
  • PTHL $32.00
  • MBOT $3.38
  • Technical
  • Relative Strength Index (RSI)
  • PTHL N/A
  • MBOT 49.29
  • Support Level
  • PTHL N/A
  • MBOT $2.43
  • Resistance Level
  • PTHL N/A
  • MBOT $3.20
  • Average True Range (ATR)
  • PTHL 0.00
  • MBOT 0.23
  • MACD
  • PTHL 0.00
  • MBOT 0.01
  • Stochastic Oscillator
  • PTHL 0.00
  • MBOT 24.69

About PTHL Pheton Holdings Ltd Class A Ordinary Shares

Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.

About MBOT Microbot Medical Inc.

Microbot Medical Inc is a clinical-stage medical device company specializing in the research, design and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is focused on leveraging its robotic technologies to redefine surgical robotics while improving surgical outcomes for patients. Using its LIBERTY technological platform, the company is developing the first-ever fully disposable robot for various endovascular interventional procedures.

Share on Social Networks: